The first things to look for in the non-commercials net change indicator are group themes. Are there similar movements in the COT data in several markets within a group? This week the answer would be no. Against the background of geopolitical concerns and a US holiday last Monday, movements in COT data have been mostly muted. Still, there was some movement again in soybeans, as well as meal and oil. And copper continues to coil but non-commercials backed off their threat to cross to the net long side of the market.
This RadarScreen capture shows the net change in the net non-commercial position, expressed as a percent of the total non-commercial open interest, in the Commitments of Traders (COT) data released Friday, September 6.
Hot Net Payout Yield Companies To Own In Right Now: iShares Short Treasury Bond ETF (SHV)
iShares Lehman Short Treasury Bond Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the short-term sector of the United States Treasury market as defined by the Lehman Brothers Short U.S. Treasury Index (the Index). The Index includes all publicly issued United States Treasury securities that have a remaining maturity of between 1 and 12 months, and have more than $250 million or more of outstanding face value. In addition, the securities must be denominated in United States dollars, and must be fixed-rate and non-convertible securities. Excluded from the Index are certain special issues, such as flower bonds, targeted investor notes, and state and local government series bonds (SLG5), and coupon issues that have been stripped from assets that are already included in the Index.
The Index is a market capitalization-weighted index. The Fund generally will invest at least 95% of its assets in the United States Government bonds. The Fund invests in a representative sample of the securities in the Index, which has a similar investment profile as the Index. The Fund�� investment advisor is Barclays Global Fund Advisor.
Advisors' Opinion: - [By Donald van Deventer]
Shorter-duration Treasury Exchange-Traded Funds: (SHY), (SHV), (IEI), (BIL), (TUZ), (FIVZ), (DTUL), (VGSH), (DTUS), (DFVS), (DFVL), (SST), (ISTB), (TBZ).
Hot Net Payout Yield Companies To Own In Right Now: Trex Company Inc.(TREX)
Trex Company, Inc. manufactures and distributes wood/plastic composite products, and related accessories primarily for the residential and commercial decking and railing applications in the United States. The company offers decking products, including Trex Transcend and Trex Enhance protective shells for protection against fading, staining, and scratching; Trex Accents that provides a smooth surface on one side and subtle wood grain on the other; Trex Escapes, a cellular PVC deck board; and Trex Hideaway, a hidden fastening system for specially grooved boards. It also provides railing products comprising Trex Designer Series Railing, which consists of a decorative top and bottom rail, refined balusters, and post caps and skirts; and Trex Transcend Railing for use with Trex decking products, as well as other decking materials. In addition, the company offers Trex Transcend Porch Flooring and Railing System, an integrated system of porch components and accessories; and fenci ng products, such as Trex Seclusions fencing product that uses interlocking pickets for privacy, and Trex Surroundings fencing that uses traditional pickets. Further, it provides TrexTrim product, a cellular PVC residential exterior trim product; steel deck framing systems under Trex Elevations name; and Trex DeckLighting, a line of energy-efficient LED dimmable deck lighting, which is designed for use on posts, floors, and steps. Additionally, the company acts as a licensor in various licensing agreements with third parties to manufacture and sell various products, including Trex Outdoor Furniture; Trex RainEscape, an above joist deck drainage system; Trex CustomCurve, an on-site system that allows contractors to heat and bend Trex products; and Trex Pergolas, a cellular PVC trim product. The company sells its products through wholesale distributors, retail lumber dealers, and Home Depot and Lowe?s stores. Trex Company, Inc. was founded in 1996 and is headquartered in Winc hester, Virginia.
Advisors' Opinion: - [By Rick Munarriz]
Then we have Trex (NYSE: TREX ) and Lumber Liquidators (NYSE: LL ) , the wood-alternative decking and hardwood-flooring retailers that posted double-digit revenue growth in their most recent quarters. Yes, those stocks trade at slightly higher multiples, but in this video longtime Fool contributor Rick Munarriz explains why they are worth it and why it might be time to trade in the orange aprons for a better alternative to both Lowe's and Home Depot stock.
Dominion Diamond Corporation, formerly Harry Winston Diamond Corporation, incorporated on March 26, 2013, is focused on the mining and marketing of rough diamonds to the global market. The Company supplies rough diamonds to the global market from production received from its 40% ownership interest in the Diavik Diamond Mine (the Diavik Diamond Mine) and its 80% interest in the Ekati Diamond Mine (the Ekati Diamond Mine). Both mineral properties are located at Lac de Gras in Canada�� Northwest Territories. On March 26, 2013, the Company completed the sale of its Harry Winston luxury brand business to the Swatch Group Ltd.
The Diavik Joint Venture (the Joint Venture) is an unincorporated joint arrangement between Diavik Diamond Mines Inc. (DDMI - 60%) and Dominion Diamond Diavik Limited Partnership (DDDLP - 40%), where DDDLP owns an undivided 40% interest in the assets, liabilities and expenses. DDMI is the operator (the Operator) of the Diavik Diamond Mine. During 2012, production at the Diavik Diamond Mine was approximately 7.2 million carats, consisting of approximately 4.3 million carats produced from 1.2 million tons of ore from the A-418 kimberlite pipe, 1.9 million carats produced from 0.4 million tons of ore from the A-154 South kimberlite pipe, and 0.9 million carats produced from 0.5 million tons of ore from the A-154 North kimberlite pipe. The Diavik Diamond Mine has three ore bodies: A-154 South, A-154 North, and A-418. An additional body of mineralization, A-21, is classified as resource.
The Ekati Diamond Mine consists of the Core Zone, which includes the operating mine and other permitted kimberlite pipes, as well as the Buffer Zone, an adjacent area hosting kimberlite pipes having both development and exploration potential. It encompasses 176 mining leases, totaling 173,024 hectares, and hosts 111 kimberlite occurrences including the Koala, Koala North, Fox, Misery, Pigeon, and Sable kimberlite pipes. The Buffer Zone is held 58.8% by the Company. It contains! 106 mining leases covering 89,151.6 hectares, and hosts 39 known kimberlite occurrences including the Jay and Lynx kimberlite pipes. As of December 31, 2012, production from the Diavik Diamond Mine has totaled 76.6 million carats of diamonds. As of December 31, 2012, production from the Ekati Diamond Mine has totaled approximately 53.54 million carats of diamonds.
Advisors' Opinion: - [By Rich Smith]
Toronto-based diamond miner Dominion Diamond (NYSE: DDC ) -- the company formerly known as Harry Winston Diamond -- has completed its purchase of BHP Billiton's (NYSE: BHP ) stake in the Ekati Diamond Mine, "as well as the associated diamond sorting and sales facilities in Yellowknife, Canada, and Antwerp, Belgium," Dominion Diamond announced Wednesday.
Hot Net Payout Yield Companies To Own In Right Now: Cenovus Energy Inc (CVE)
Cenovus Energy, Inc. (Cenovus), incorporated on January 1, 2011, is a Canadian integrated oil company. The Company�� operations include oil sands projects in northern Alberta, which use specialized methods to drill and pump the oil to the surface. It also has natural gas and oil production in Alberta and Saskatchewan. It operates in four segments: oil sands, conventional, refining and marketing, and corporate and eliminations. The Company has 50% ownership with Phillips 66 in two United States refineries, which includes Wood River (Illinois) and Borger (Texas) refineries. It has two producing steam-assisted gravity drainage (SAGD) projects in the oil sands-Foster Creek and Christina Lake, as well as several emerging projects which are in various stages of development. Foster Creek and Christina Lake are 50%-owned by ConocoPhillips. It also produces heavy oil from the mobile Wabiskaw formation at its 100%-owned Pelican Lake operation in the Greater Pelican Region, about 300 kilometers north of Edmonton.
Its reserves and production are located in Canada, primarily within the provinces of Alberta and Saskatchewan. As of December 31, 2012, it had a land base of approximately seven million net acres and Company Interest Before Royalties proved reserves of approximately 1,717 million barrels of bitumen, 184 million barrels of heavy crude oil, 115 million barrels of light and medium crude oil and NGLs and 955 billion cubic feet of natural gas. It also had Company Interest Before Royalties probable reserves of approximately 676 million barrels of bitumen, 105 million barrels of heavy crude oil, 56 million barrels of light and medium crude oil and natural gas liquefied (NGLs) and 338 billion cubic feet of natural gas as of December 31, 2012.
Oil Sands
The Oil sands segment includes the development and production of Cenovus�� bitumen assets at Foster Creek, Christina Lake and Narrows Lake, as well as heavy oil assets at Pelican Lake. This segment also includes the Atha! basca natural gas assets and projects in the early stages of development, such as Grand Rapids and Telephone Lake. Certain of the Company�� operated oil sands properties, notably Foster Creek, Christina Lake and Narrows Lake, are jointly owned with ConocoPhillips. As of December 31, 2012, it had bitumen rights of approximately 1,469,000 gross acres (1,097,000 net acres) within the Athabasca and Cold Lake areas, as well as the exclusive rights to lease an additional 478,000 net acres areas on the Cold Lake Air Weapons Range on its behalf and/or its assignee�� behalf.
As of December 31, 2012, there were 56 wells producing. It operates an 80 megawatt natural gas-fired cogeneration facility in conjunction with the SAGD operation at Foster Creek. The steam and power generated by the facility is presently being used within the SAGD operation and the excess power generated is being sold into the Alberta Power Pool. It has 50% interest in Christina Lake, an oil sands property in northeast Alberta that uses SAGD technology and produces from the McMurray formation. During 2011, the Company drilled three wells at Christina Lake using its Wedge WellTM technology. As of December 31, 2012, there were six producing wells.
The Company holds 50% interest in Narrows Lake, an oil sands property within the Christina Lake Region in northeast Alberta. The project includes gross production capacity of 130,000 barrels per day (bbls/d) of bitumen to be developed in up to three phases, with the first phase expected to have production capacity of approximately 45,000 barrels per day of bitumen. Using a pattern, horizontal well polymer flood, it produces heavy crude oil from the Cretaceous Wabiskaw formation at its Pelican Lake property, which is located within the Greater Pelican Region in northeast Alberta. During 2012, it drilled 76 heavy oil wells. The Company holds a 38% non-operated interest in 110 kilometers, 20-inch diameter crude oil pipeline, which connects the Pelican Lake area to a pipelin! e that tr! ansports crude oil from northern Alberta to crude oil markets.
The Company�� new resource play assets include oil sands properties. Its Grand Rapids property is located in the Greater Pelican Region in northeast Alberta, where deposits of bitumen have been identified in the Cretaceous Grand Rapids formation. Its Telephone Lake property is located in the Borealis Region in northeast Alberta. The Steepbank and East McMurray properties are also located in the Borealis Region, southwest of Telephone Lake. It produces natural gas from the Cold Lake Air Weapons Range and several surrounding landholdings located in northeast Alberta and hold surface access and natural gas rights for exploration, development and transportation from areas. The majority of its natural gas production in the area is processed through wholly owned and operated compression facilities.
Conventional
Conventional segment includes the development and production of conventional crude oil, NGLs and natural gas in Alberta and Saskatchewan. It includes the carbon dioxide enhanced oil recovery project at Weyburn and emerging tight oil opportunities. As of December 31, 2012, it had an established land position of approximately 4.9 million gross acres, of which approximately 3.2 million gross acres are developed. The mineral rights on approximately 59% of its net landholdings are owned in fee title by Cenovus. It leases Crown lands in some areas in Alberta, mainly in the Early Cretaceous geological formations, primarily in the Suffield and Wainwright areas.
The Company holds interests in multiple zones in the Suffield, Brooks North, Langevin, Drumheller, and Wainwright areas in southern Alberta with a mix of medium and heavy crude oil production. Development in these areas focuses on infill drilling, optimization of existing wells and other specialized oil recovery methods. It operates water handling facilities to manage oil production. In the unitized portion of the Weyburn crude oil field ! in southe! ast Saskatchewan, it has 62% working interest. The Weyburn unit produces light and medium sour crude oil from the Mississippian Midale formation and covers 78 sections of land. As of December 31, 2012, approximately 90% of the approved CO2 flood pattern development at the Weyburn unit was completed. It holds interests in multiple zones in the Suffield, Brooks North, Langevin and Drumheller areas in southern Alberta.
Refining and Marketing
Refining and marketing segment is focused on the refining of crude oil products into petroleum and chemical products at two refineries located in the United States. The refineries are jointly owned with and operated by Phillips 66. This segment also markets Cenovus�� crude oil and natural gas, as well as third-party purchases and sales of product that provide operational flexibility for transportation commitments, product type, delivery points and customer diversification.
Through WRB Refining LP (WRB), the Company has 50% ownership interest in both the Wood River and Borger Refineries located in Roxana, Illinois and Borger, Texas respectively. ConocoPhillips is the operator and manager of WRB. As of December 31, 2012, the Wood River refinery had a processing capacity of approximately 306,000 barrels per day of crude oil, including approximately 110,000 barrels per day of heavy crude oil. It processes light low-sulphur and heavy high-sulphur crude oil that it receives from North American crude oil pipelines to produce gasoline, diesel and jet fuel, petrochemical feedstocks and asphalt. As December 31, 2012, the Borger Refinery had a processing capacity of approximately 146,000 barrels per day of crude oil, including approximately 35,000 barrels per day of heavy crude oil, and approximately 45,000 barrels per day of NGLs. It processes crude oil and NGLs that it receives from North American pipeline systems to produce gasoline, diesel and jet fuel along with NGLs and solvents.
The Company's Marketing group is focused ! on enhanc! ing the netback price of its production. It manages the transportation and marketing of crude oil for its upstream operations. It also manages the marketing of its natural gas, which is primarily sold to industrials, other producers and energy marketing companies.
Corporate and Eliminations
The segment includes inter-segment eliminations that relate to transactions that have been recorded at transfer prices based on current market prices, as well as unrealized intersegment profits in inventory. The Corporate and Eliminations segment also includes Cenovus costs for general and administrative and financing activities.
Advisors' Opinion: - [By gurujx]
Cenovus Energy, Inc. (CVE) Reached the 3-year Low of $28.17
The prices of Cenovus Energy, Inc. (CVE) shares have declined to close to the 3-year low of $28.17, which is 33.3% off the 3-year high of $40.73.
- [By Stephan Dube]
Athabasca's most notable producers:
Suncor Energy (SU) (Part 1), see article here.Suncor Energy (Part 2), see article here.Athabasca Oil (ATHOF.PK), see article here.Canadian Natural Resources, see article here.Imperial Oil, see article here.Cenovus Energy (CVE), see article here.MEG Energy (MEGEF.PK), see article here.Devon Energy, see article here.Royal Dutch Shell, see article here.Ivanhoe Energy (IVAN), see article here.Nexen (CNOOC) (CEO), see article here.An analysis of the current operations of the company will be examined with the objective to provide the most complete information available to potential investors before deciding to seize the opportunity that the 54,132 square miles of the Carbonate Triangle has to offer. Let's start by introducing Athabasca, a famous and most prolific region in the Canadian oil sands as well as one of the largest reserve in the world.
- [By Aaron Levitt]
Realizing the error of its ways — i.e. spinning off its oil division as Cenovus (CVE) in 2009 — EnCana (ECA) has been spending much of the past year reinventing itself as a more balanced energy play rather than a strictly natural gas one. That has meant adding more liquids and shale oil back into its production mix.
Hot Net Payout Yield Companies To Own In Right Now: Stemline Therapeutics Inc (STML)
Stemline Therapeutics, Inc. (Stemline), incorporated on August 8, 2003, is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics that target both cancer stem cells (CSCs) and tumor bulk. The Company is developing two clinical-stage product candidates, SL-401 and SL-701, for which it holds global marketing rights. The indication for SL-401, a biologic-drug conjugate, is acute myeloid leukemia (AML). The indications for SL-701, a synthetic peptide vaccine, are pediatric and adult brain cancer. It has a platform, StemScreen, for the discovery of CSC-targeted compounds, from which it has discovered or validated several of its clinical and preclinical product candidates. Stemline�� StemScreen consists of StemScreen-1 and StemScreen-2 for the identification of CSC-directed compounds.
SL-301 is a small molecule gamma-secretase inhibitor that inhibits Notch, a pathway expressed by CSCs and tumor bulk of multiple cancer types. SL-101 is a monoclonal antibody-based (mAb -based) compound that targets CD123 and has shown in vitro activity against certain hematologic cancers. SL-201 is a small molecule active against certain hematologic and solid tumor types. SL-601 is a mAb-based compound that targets a cell surface marker on bladder CSCs, which is also expressed on a variety of other solid tumor types. It has also in-licensed certain intellectual property directed to mAb-based therapeutics to validated oncology targets, including Glypican-3, Tie-1, CD133, Frizzled, Smoothened and Patched.
SL-401 - An IL-3R-Directed Compound Targeting Cancer Stem Cells and Tumor Bulk
SL-401 is a clinically active biologic-drug conjugate consisting of human interleukin-3 (IL-3) genetically linked to a truncated version of diphtheria toxin. SL-401 targets the IL-3 receptor (IL-3R), which is overexpressed on both the CSCs and tumor bulk of multiple hematologic cancers, including AML. SL-401 has demonstrated preclinical in vit! ro and in vivo activity against both leukemia blasts (which includes tumor bulk) and CSCs of a range of human leukemia cell lines and primary leukemia cells from patients.
SL-701
SL-701 is a clinically active synthetic peptide vaccine that targets several epitopes on CSCs and tumor bulk of brain cancer. In two completed Phase 1/2 clinical trials, SL-701 demonstrated single agent anti-tumor activity in pediatric patients with newly diagnosed brainstem glioma (BSG) and other high-grade gliomas (HGGs) and in adult patients with refractory or recurrent GBM, and other HGGs.
StemScreen-1
StemScreen-1 is a drug discovery platform designed to identify CSC-targeted compounds based on the isolation of CSCs and evaluation of CSC gene expression profiles. CSCs are isolated from primary tumor tissue or cell lines, and then subjected to gene expression analysis using a variety of technologies, including microarray. A control tissue, such as normal bone marrow is analyzed as a comparator against the gene expression profile of the isolated CSCs. These data are then interfaced with an information base of compounds and their mechanisms of action (that is which gene products and pathways they impact). It has utilized StemScreen-1 to discover a number of its preclinical drug candidates. These include SL-201, SL-301, and SL-601. In addition, SL-401 demonstrated activity against CSCs as determined by both an in vitro colony formation and in vivo animal implantation assay, thereby validating certain StemScreen-1 anti-CSC assays.
StemScreen-2
StemScreen-2 is a high throughput drug discovery platform it is developing to discover anti-CSC compounds. StemScreen-2 utilizes a cell-based assay that can track and follow CSCs in their natural state during high throughput screening. In particular, StemScreen-2 utilizes a CSC-specific promoter linked to a reporter as a method for identifying and following CSCs in their native environment of surrounding tumor b! ulk. In t! his way, StemScreen-2 enables the identification of compound hits, in a high throughput manner, with anti-CSC activity.
The Company competes with Boston Biomedical, Inc., Eclipse Therapeutics, Inc., OncoMed Pharmaceuticals, Inc., Verastem, Inc., Astellas Pharma US, Inc., Boehringer Ingelheim GmbH, Dainippon Sumitomo Pharma Co. Ltd., Geron Corp., GlaxoSmithKline plc, ImmunoCellular Therapeutics, Ltd, Macrogenics Inc., Amgen, Inc., Pfizer Inc., Roche Holding AG, Sanofi U.S. LLC., Cyclacel Pharmaceuticals, Inc., Sunesis Pharmaceuticals Inc., Clavis Pharma ASA, Ambit Biosciences Corporation, Celgene Corporation, Eisai Co. Ltd., Celator Pharmaceuticals, Inc., Merck & Co., Inc., Eisai Co., Inc., Roche Holding AG, Novartis AG and Celldex Therapeutics, Inc.
Advisors' Opinion: - [By Keith Speights]
Best-performing biotech IPO
Stemline Therapeutics� (NASDAQ: STML ) has only traded publicly this year, but what a year it's been. The stock's performance ranks Stemline as the best-performing biotech IPO so far in 2013. This week has been pretty good also, with shares moving up by 28%.
Hot Net Payout Yield Companies To Own In Right Now: Scholastic Corporation(SCHL)
Scholastic Corporation, together with its subsidiaries, operates as a children?s publishing, education, and media company primarily in the United States. The company?s Children?s Book Publishing and Distribution segment publishes and distributes children?s books through school-based book clubs and book fairs, ecommerce, and the trade channel in the United States. Its Educational Publishing segment publishes and distributes educational technology products and services, curriculum materials, children?s books and collections, classroom magazines, and print and online reference and non-fiction products for grades pre-K to 12 to schools and libraries in the United States. The company?s Media, Licensing, and Advertising segment creates and produces programming and digital content for various platforms, including television, DVDs, audio, movies, interactive games, applications, and Websites. This segment produces and sells a television library consisting of approximately 50 0 half-hour productions; produces television programming, including the animated series; creates audiovisual adaptations of classic children?s picture books; produces young adult and children?s audio recordings; and creates original and licensed consumer software, including handheld and console products with accessories and mobile applications for grades pre-K to 8. This segment also develops sponsored educational materials and supplementary classroom programs in partnership with government agencies, nonprofit organizations, and business organizations; and operates a direct-to-home catalog business specializing in children?s toys. Its International segment publishes and distributes products and services in Canada, the United Kingdom, Australia, New Zealand, Ireland, India, China, Singapore, and other parts of Asia, as well as includes its export and foreign rights businesses. Scholastic Corporation was founded in 1920 and is headquartered in New York, New York.
Advisors' Opinion: - [By Jon C. Ogg]
Teradyne will replace Scholastic Corp. (NASDAQ: SCHL) in the S&P MidCap 400, and Scholastic will replace Lincoln Education Services Corp. (NASDAQ: LINC) in the S&P SmallCap 600. Lincoln Education Services currently ranks 600th in the S&P SmallCap 600 and is no longer representative of the small cap market space.
- [By Jeremy Bowman]
What: Shares of Scholastic (NASDAQ: SCHL ) were sliding again today, falling as much as 10% after the company posted another disappointing earnings report.
Hot Net Payout Yield Companies To Own In Right Now: Santa Fe Gold Corp (SFEG)
Santa Fe Gold Corporation (Santa Fe), incorporated in August 1991, is a mining company. As of June 30, 2012, the Company had four projects: its Summit silver-gold and Ortiz gold projects located in New Mexico, and its Black Canyon mica and Planet micaceous iron oxide projects located in Arizona. The Company has constructed a mill and are developing an underground mine at its Summit silver-gold project. Santa Fe�� Summit operations in southwestern New Mexico are conducted through its wholly owned subsidiary, The Lordsburg Mining Company. Its mica operations in Arizona are conducted through its wholly owned subsidiary, Azco Mica Inc. Santa Fe�� activity in Mexico is conducted through its wholly owned subsidiary, Minera Sandia, S.A. de C.V.
Summit Silver-Gold Project
The Summit silver-gold project includes the underground Summit silver-gold mine and related property consisting of 117 acres of patented mining claims and 740 acres of unpatented mining claims in Grant County, southwestern New Mexico, and the Banner mill, including mineral processing equipment consisting of a crushing and screening plant, a ball mill and a 400 ton-per-day flotation plant, and related property consisting of approximately 1,500 acres of wholly owned and leased patented and unpatented mining claims, located approximately 57 miles south of the Summit mine near Lordsburg, Hidalgo County, New Mexico. It owns and operates the Summit project under the Lordsburg Mining Company, a wholly-owned subsidiary. The Summit silver-gold property is located in Grant County, southwestern New Mexico, near the Arizona state line. The Banner mill site lies 57 miles to the south of the Summit property near the town of Lordsburg, Hidalgo County, New Mexico.
Santa Fe�� holdings at the Summit silver-gold property in Grant County, New Mexico consist of 10 patented federal mining claims totaling approximately 117 acres and 62 unpatented federal mining claims totaling approximately 740 acres. Its holdings at an! d adjacent to the Banner mill site in Hidalgo County, New Mexico consists of 86 wholly owned patented federal mining claims, 16 wholly owned unpatented mining claims, 17 leased patented mining claims and 6 leased unpatented mining claims, aggregating approximately 1,500 acres. All wholly owned claims are held in the name of Lordsburg Mining.
Ortiz Gold Project
The Ortiz Mine Grant, over which the Company holds a lease on the mineral estate underlying 42,297 acres (66 square miles) of segregated surface estate, is located 30 miles by road northeast of Albuquerque, Santa Fe County, New Mexico.
The Ortiz Mine Grant is underlain by mid-Tertiary monzonite and latite porphyry stocks, plugs, dikes and sills that have intruded Paleozoic to early-Tertiary sedimentary rocks. The intrusive rocks are part of the Ortiz Porphyry Belt, which comprises from north to south, the Cerrillos Hills, the Ortiz Mountains, the San Pedro Mountains, and South Mountain.
Black Canyon Mica Project
The Black Canyon mine is located 30 miles north of Phoenix, Arizona, and 3.5 miles west-southwest of Black Canyon City. The Glendale processing plant was located in an industrial area on the west side of Phoenix, Arizona, 47 miles to the south of the mine site. Its property holdings at and around the Black Canyon mine consists of 67 federal unpatented mining claims in Yavapai County, Arizona and nine federal unpatented mill site claims in Maricopa County, Arizona, which in total cover approximately 1,385 acres.
Planet Micaceous Iron Oxide (MIO) Project
The Planet property consists of thirty-one patented mining claims totaling 523 acres located in western Arizona. The Planet property is located in the northwest corner of La Paz County, west central Arizona. The property consists of thirty-one patented mining claims totaling 523 acres, consisting of an area of 3,600 feet wide by 8,000 feet long.
Lordsburg Exploration Project
T! he Compan! y in the the Lordsburg (Virginia) Mining District controls approximately 1,500 acres of prospective ground, the majority of which is comprised of patented mining claims that it owns, and the remainder patented and unpatented mining claims that it leases. As of June 30, 2012, the Company had completed an aerial mapping survey covering 30 square miles, carried out data compilation, conducted detailed geologic mapping and sampling, and conducted a geophysical survey.
Advisors' Opinion: - [By CRWE]
Today, SFEG has shed (-0.32%) down -0.001 at $.154 with�50,738 shares in play thus far (ref. google finance Delayed: 11:43AM EDT July 12, 2013), but don�� let this get you down.
Santa Fe Gold Corporation previously reported it has amended the Mogollon option agreement with Columbus Exploration Corporation (CLX-TSX-V) (formerly Columbus Silver Corporation) under which Santa Fe may earn 100% interest in the Mogollon Project, Catron County, New Mexico. The Mogollon Project encompasses most of the Mogollon district in southwest New Mexico, which has substantial recorded historical production of silver and gold. The project fits Santa Fe�� strategic objective of developing new ore sources to augment ore currently processed though its Lordsburg flotation mill.
- [By CRWE]
Today, SFEG surged (+8.33%) up +0.010 at $.130 with 166,303 shares in play thus far (ref. google finance Delayed: 11:59AM EDT July 8, 2013).
Santa Fe Gold Corporation previously reported its Annual Stockholder Meeting is scheduled to be held at 10:00 a.m. Mountain Time on Tuesday, August 6, 2013, at the Albuquerque Marriott Hotel located at 2101 Louisiana Blvd NE, Albuquerque, NM 87110. Santa Fe Gold Corporation is a gold and silver producer with operations in New Mexico. Its Summit mine achieved commercial production in 2012. Summit produces high value gold-silver concentrates and silica flux products that are sold under contract to domestic and overseas smelters.
- [By CRWE]
Today, SFEG has shed (-11.76%) down -0.016 at $.123 with 30,280 shares in play thus far (ref. google finance Delayed: 10:48AM EDT July 16, 2013), but don�� let this get you down.
Santa Fe Gold Corporation previously reported it has amended the Mogollon option agreement with Columbus Exploration Corporation (CLX-TSX-V) (formerly Columbus Silver Corporation) under which Santa Fe may earn 100% interest in the Mogollon Project, Catron County, New Mexico. The Mogollon Project encompasses most of the Mogollon district in southwest New Mexico, which has substantial recorded historical production of silver and gold. The project fits Santa Fe�� strategic objective of developing new ore sources to augment ore currently processed though its Lordsburg flotation mill.
- [By CRWE]
Today, SFEG remains (0.00%) +0.000 at $.139 with�31,100 shares in play thus far (ref. google finance Delayed: 11:35AM EDT July 10, 2013).
Santa Fe Gold Corporation previously reported it will receive an additional A$2.0 million from International Goldfields Limited (ASX: IGS), by way of a secured convertible note, increasing IGS��investment in Santa Fe to A$6.0 million. The funds will be used for working capital in support of improvement to mining operations.
In conjunction with the IGS financing, Santa Fe is exploring a listing on the Singapore Catalist Stock Exchange (SGX-ST). Pierce Carson, CEO of Santa Fe said, ��ith the assistance of IGS and our Singapore-based financial advisor, we have formulated a clear strategy to improve our balance sheet, bring the Summit gold-silver mine into full project performance, refinance our senior secured debt and enhance Santa Fe�� trading market for our stockholders.��/p>
Hot Net Payout Yield Companies To Own In Right Now: Oceaneering International Inc.(OII)
Oceaneering International, Inc., together with its subsidiaries, provides engineered products and services primarily to the offshore oil and gas industry with a focus on deepwater applications. The company?s Remotely Operated Vehicles segment provides submersible vehicles operated from the surface to support offshore oil and gas exploration, production, and construction activities. Its Subsea Products segment supplies various built-to-order specialty subsea hardware products. The company?s Subsea Projects segment provides multiservice vessels, oilfield diving, and support vessel operations, which are used primarily in inspection, repair, and maintenance and installation activities; and mobile offshore production systems. Its Inspection segment offers customers with a range of third-party inspection services to satisfy contractual structural specifications, internal safety standards, and regulatory requirements. The company?s Advanced Technologies segment offers project management, and engineering services and equipment for applications in non-oilfield markets. Oceaneering International, Inc. also serves defense and aerospace industries. It operates primarily in west Africa, Norway, the United Kingdom, Asia, Australia, Brazil, and the United States. The company was founded in 1965 and is based in Houston, Texas.
Advisors' Opinion: - [By Jeremy Bowman]
What: Shares of Oceaneering International (NYSE: OII ) were rising with the tide today, gaining as much as 10% after delivering a strong quarter and a healthy dividend hike.
- [By David Smith]
I recently described to Fools why I believe National Oilwell Varco (NYSE: NOV ) , Cameron International (NYSE: CAM ) , and Oceaneering International (NYSE: OII ) all stand to benefit from the steady march of the global oil industry into progressively deeper waters.
Hot Net Payout Yield Companies To Own In Right Now: W.R. Berkley Corporation(WRB)
W. R. Berkley Corporation, an insurance holding company, operates as commercial lines writers in the property casualty insurance business primarily in the United States. The company operates in five segments: Specialty, Regional, Alternative Markets, Reinsurance, and International. The Specialty segment underwrites third-party liability risks, primarily excess, and surplus lines, including premises operations, professional liability, commercial automobile, products liability, and property lines. The Regional segments provide commercial insurance products to small-to-mid-sized businesses, and state and local governmental entities primarily in the 45 states of the United States. The Alternative Markets segment develops, insures, reinsures, and administers self-insurance programs and other alternative risk transfer mechanisms. This segment offers its services to employers, employer groups, insurers, and alternative market funds, as well as provides a range of fee-based servic es, including consulting and administrative services. The Reinsurance segment engages in the underwriting property casualty reinsurance on a treaty and a facultative basis, including individual certificates and program facultative business; and specialty and standard reinsurance lines, and property and casualty reinsurance. The International segment offers personal and commercial property casualty insurance in South America; commercial property casualty insurance in the United Kingdom and continental Europe; and reinsurance in Australia, Southeast Asia, and Canada. The company was founded in 1967 and is based in Greenwich, Connecticut.
Advisors' Opinion: Hot Net Payout Yield Companies To Own In Right Now: Oramed Pharmaceuticals Inc (ORMP)
Oramed Pharmaceuticals Inc., incorporated on March 10, 2011, is a development-stage pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet to be used for the treatment of individuals with diabetes, use of orally ingestible capsules, tablets or pills for delivery of other polypeptides. The Company owns oral dosage form drug portfolio, it is, on an on-going basis, considering in-licensing and other means of obtaining additional technologies to complement and/or expand the product portfolio. The Company�� products include ORMD-0801 - Oral Insulin Capsule and ORMD-0901 - Oral Exenatide.
The Company focuses to conduct research and development on the technology covered by the patent application Methods and Composition for Oral Administration of Proteins. Through its research and development efforts, it focuses to develop an oral dosage form that will withstand the chemical environment of the stomach and intestines and will be effective in delivering active insulin for the treatment of diabetes. It intends to conduct the clinical trials to file an Investigational New Drug (IND), application with the United States Food and Drug Administration (FDA). It also focuses to conduct research and development by deploying its drug delivery technology for the delivery of other polypeptides in addition to insulin, and to develop other pharmaceutical products.
Advisors' Opinion: Hot Net Payout Yield Companies To Own In Right Now: Synutra International Inc.(SYUT)
Synutra International, Inc., through its subsidiaries, engages in the production, marketing, and distribution of dairy based nutritional products primarily in the People?s Republic of China. The company offers powdered infant and adult formula products for adults and children under the Super, U-Smart, My Angel, Mingshan, and Helanruniu brand names; prepared baby food for babies and children under the Huiliduo brand name; and nutritional ingredients and supplements, such as chondroitin sulfate, microencapsulated Docosahexanoic Acid, and Arachidonic Acid. It also sells milk powder, whey protein, and raw milk to industrial customers. The company markets its products under Shengyuan or Synutra brands. It sells its products through sales and distribution network covering 30 provinces and provincial-level municipalities in China. Synutra International, Inc. is headquartered in Rockville, Maryland.
Advisors' Opinion: - [By Seth Jayson]
Synutra International (Nasdaq: SYUT ) is expected to report Q4 earnings on June 13. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Synutra International's revenues will contract -9.1% and EPS will decrease -84.6%.
- [By Seth Jayson]
Synutra International (Nasdaq: SYUT ) reported earnings on June 13. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q4), Synutra International missed estimates on revenues and beat expectations on earnings per share.
Hot Net Payout Yield Companies To Own In Right Now: Tesco PLC (TSCDY)
Tesco PLC, incorporated on November 27, 1947, is engaged in retailing and associated activities in the United Kingdom, China, the Czech Republic, Hungary, the Republic of Ireland, India, Malaysia, Poland, Slovakia, South Korea, Thailand and Turkey. The Company also provides retail banking and insurance services through its subsidiary, Tesco Bank. The Company�� operations in the United Kingdom is the within the Company, with over 3,000 stores. The Company�� in-store picking model is complemented by a small number of specialized dotcom-only stores, which allow the Company to respond to customer demand. The Company�� Click & Collect service is a part of its multichannel offering and enables customers to pick up their shopping when and where it suits them. It has over 1,500 Click & Collect collection points for general merchandise and over 150 Grocery Drive-thrus in the United Kingdom.
The Company�� operations in India include sourcing and its service centre, as well as a franchise arrangement with Tata Group. The Company�� Hindustan Service Centre (HSC) is the global services arm for Tesco worldwide, providing business services for Tesco operations globally. Tesco HSC is engaged in creating and executing strategic initiatives covering information technology (IT), Financial, Commercial and Property, among others. The Company also provides 80% of the stock sold by Star Bazaar, both food and non-food, sourced through its distribution centre in Mumbai. This distribution centre also provides wholesale products to traditional Indian retailers, kirana stores, restaurants and other businesses, providing small farmers and other suppliers with a way to sell their wares to the local market.
The Company has an online business and 22 of virtual stores in South Korean subways and bus stops, which help time-pressed customers, shop on-the-go using their smartphones. Tesco Lotus is its international business, serving over 11 million customers every week in over 1,400 stores. Tesco Bank! offer a range of simple personal banking products, principally-mortgages, credit cards, personal loans, and savings.
Advisors' Opinion: - [By Kevin Godbold]
So, this series aims to identify appealing FTSE 100 investment opportunities, and today ,I'm looking at Tesco (LSE: TSCO ) (NASDAQOTH: TSCDY ) , the well-known supermarket chain.
Hot Net Payout Yield Companies To Own In Right Now: Coronado Biosciences Inc (CNDO)
Coronado Biosciences, Inc., incorporated on June 28, 2006, is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. The Company�� two principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201 (TSO) a biologic comprising of the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases, such as Crohn�� disease (Crohn��), ulcerative colitis (UC) and multiple sclerosis (MS), and CNDO-109, a compound that activates natural killer (NK) cells of the immune system to seek and destroy cancer cells, for the treatment of acute myeloid leukemia (AML). In January 2011, the Company acquired the OvaMed GmbH License.
TSO
TSO is the microscopic eggs of a parasitic helminth, or worm, that is found in pigs. In September 2011, the Company filed an Investigational New Drug Application (IND) with the United States Food and Drug Administration (FDA) and it initiated a single dose, dose escalation study in patients with Crohn�� in February 2012. The Phase 1 clinical trial was a multi-center, sequential dose-escalation, double-blind, placebo-controlled study, the primary objective of which was to evaluate the safety and tolerability of TSO. The trial enrolled 36 patients with Crohn�� ranging in age from 20 to 54 with an equal distribution of male and female patients in three single dose cohorts of orally administered 500, 2500 and 7500 ova. Each cohort had 12 patients, with nine patients receiving TSO and three receiving placebo.
CNDO-109
CNDO-109 is a lysate (disrupted CTV-1 cells, cell membrane fragments, cell proteins and other cellular components) that activates donor NK cells. CTV-1 is a leukemic cell line recently re-classified as a T-cell acute lymphocytic leukemia (ALL). The Company has worldwide rights to develop and commercialize CNDO-109 activated NK cells for the treatment of cancer fro! m UCLB. In February 2012, the Company submitted an IND for the CNDO-109 activated NK cell product in the United States. The treatment of patients with CNDO-109 activated NK cells involves several steps. The activated NK cells are infused into the patient after resting NK cells are incubated with CNDO-109 for at least eight hours. Preparation of CNDO-109 activated NK cells takes about 24 hours from start to finish.
The Company competes with Centocor Ortho Biotech Inc.�� Remicade , UCB S.A.�� Cimzia, Abbott Laboratories��Humira, Biogen Idec�� Avonex, Bayer Healthcare Pharmaceuticals��Betaseron, Teva Pharmaceuticals Industries, Ltd.�� Copaxone and Novartis AG�� Gilenya.
Advisors' Opinion: - [By CRWE]
Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, reported that it has filed a registration statement with the Securities and Exchange Commission for a proposed public offering of 2,000,000 shares of its common stock. All shares proposed to be included in the offering will be sold by the company.
- [By Roberto Pedone]
One under-$10 biopharmaceutical player that's quickly moving within range of triggering a major breakout trade is Coronado Biosciences (CNDO), which is focused on novel immunotherapy biologic agents for autoimmune diseases and cancer. This stock has been hit hard by the bears in 2013, with shares off by 43%.
If you take a look at the chart for Coronado Biosciences, you'll notice that this stock has been uptrending strong since it double bottomed in November, with shares moving higher from its low of $1.25 to its intraday high of $2.58 a share. During that uptrend, shares of CNDO have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of CNDO within range of triggering a major breakout trade.
Traders should now look for long-biased trades in CNDO if it manages to break out above some key overhead resistance at $2.70 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.97 million shares. If that breakout hits soon, then CNDO will set up to re-fill some of its previous gap down zone from October that started near $7 a share. Some possible upside targets if CNDO gets into that gap with volume are $4 to $5 a share.
Traders can look to buy CNDO off any weakness to anticipate that breakout and simply use a stop that sits right around some key near-term support at $2 a share. One can also buy CNDO off strength once it takes out $2.70 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Roberto Pedone]
Coronado Biosciences (CNDO) is a biopharmaceutical company focused on novel immunotherapy biologic agents for autoimmune diseases and cancer. This stock closed up 4.9% to $8.22 in Thursday's trading session.
Thursday's Range: $7.84-$8.29
52-Week Range: $4.00-$12.70
Thursday's Volume: 323,000
Three-Month Average Volume: 390,192
From a technical perspective, CNDO spiked higher here right above its 200-day moving average of $7.63 with decent upside volume. This stock has been downtrending badly for the last three months, with shares falling from its high of $12.70 to its recent low of $7.32. During that move, shares of CNDO have been consistently making lower highs and lower lows, which is bearish technical price action. Shares of CNDO now look ready to reverse that trend and potentially trigger a near-term breakout trade. That trade will hit if CNDO manages to take out some near-term overhead resistance levels at $8.56 to $8.94 with high volume.
Traders should now look for long-biased trades in CNDO as long as it's trending above its 200-day at $7.63 or above more support at $7.32 and then once it sustains a move or close above those breakout levels with volume that hits near or above 390,192 shares. If that breakout hits soon, then CNDO will set up to re-test or possibly take out its next major overhead resistance levels at $9.50 to $10.35. Any high-volume move above those levels will then put its next major resistance level at $11 into range for shares of CNDO.